P0917n-acetyl cysteine fails to impact on plasma antioxidant capacity in both a placebo controlled crossover study and a parallel group trial of patients with ckd stage iii: implications for its use as a prophylactic for contrast induced nephropathy
Research output: Contribution to conference › Abstract
Fingerprint
Dive into the research topics of 'P0917n-acetyl cysteine fails to impact on plasma antioxidant capacity in both a placebo controlled crossover study and a parallel group trial of patients with ckd stage iii: implications for its use as a prophylactic for contrast induced nephropathy'. Together they form a unique fingerprint.